The association between infections and chemotherapy interruptions among cancer patients: Prospective cohort study
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Doxorubicin-induced ovarian toxicity – topic of research paper in Veterinary science. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry – ScienceOpen
Oncology Education | Videos
Transnational cancer research lab | Felsenstein Medical Research Center
Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology
Ribociclib Improves Progression-Free Survival for Women with Metastatic Breast Cancer
Can-Fite to Treat Advanced Liver Cancer Patients with Namodenoson Under Compassionate Use Setting in Israel | Business Wire
Congratulations to Dr. Prasanna Alluri,... - UT Southwestern Radiation Oncology | Facebook
The value of source data verification in a cancer clinical trial
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Collaterals
Transnational cancer research lab | Felsenstein Medical Research Center
PLOS ONE: Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
GRAPES: A CANCER CELL INHIBITOR?
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
Faculty | CoBrCa – Controversies in Breast Cancer
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
GRAPES: A CANCER CELL INHIBITOR?
